US Media Blackout: Italian Courts Rule Vaccines Caused Autism

by Vins
Published: Updated:

Like the U.S., Italy has a national vaccine injury compensation program, giving financial support to those people injured by vaccinations. On September 23, 2014, an Italian court in Milan awarded compensation to a previously healthy boy for vaccine-induced autism after receiving three doses of GlaxoSmithKline’s Infanrix Hexa, a hexavalent vaccine administered in the first year of life to protect children from polio, diphtheria, tetanus, hepatitis B, pertussis and Haemophilus influenza type B. In addition to these antigens, however, the vaccine also contained thimerosal, the mercury-containing preservative, aluminum, an adjuvant, as well as other toxic ingredients. The child regressed into autism shortly after receiving the three doses.

Based on expert medical testimony, the court concluded that the child more than likely suffered autism and brain damage because of the neurotoxic mercury and aluminum in the vaccine as well as his particular susceptibility from a genetic mutation. Presiding Judge Nicola Di Leo considered another piece of damning evidence, a 1271-page confidential GlaxoSmithKline report. This industry document provided ample evidence of adverse events from the vaccine, including five known cases of autism resulting from the vaccine’s administration during its clinical trials.

Two years earlier, an Italian court found that a Measles-Mumps-Rubella vaccine (MMR) had caused autism in a 15-month-old boy. Taken together, the court found that both the MMR and the hexavalent thimerosal and aluminum-containing vaccine could trigger autism. These court decisions flatly contradict the decisions from the U.S. vaccine court based on similar claims. The Italian press has devoted considerable attention to this decision and its public health implications, while the U.S. press has been silent.

Source: Mary Holland, “U.S. Media Blackout: Italian Courts Rule Vaccines Cause Autism,” Global Research, February 13, 2015,

Student Researcher: Stephanie Armendariz (San Francisco State University)

Faculty Evaluator: Kenn Burrows (San Francisco State University)